PAVmed reported a quarterly loss of $1.17 per share, wider than the Zacks Consensus Estimate loss of $0.69. The loss also remained negative versus a $2.10 per-share loss a year ago, though the year-over-year loss narrowed.
PAVmed reported a quarterly loss of $1.17 per share, wider than the Zacks Consensus Estimate loss of $0.69. The loss also remained negative versus a $2.10 per-share loss a year ago, though the year-over-year loss narrowed.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly negative
Sentiment Score
-0.55
Ticker Sentiment
